Key takeaway
A biostimulant should be evaluated by its intended function, the conditions under which a claimed effect has been demonstrated, and the strength and relevance of the evidence. Ingredients alone do not answer these questions.
The question
What should a business, researcher or agricultural partner examine when considering a biostimulant? A useful evaluation begins with three questions: what function is intended, under which conditions has the claimed effect been demonstrated, and how relevant is that evidence to the proposed use?
Africa’s soils are highly diverse. FAO’s SoilFER combines soil, climate, terrain and crop information to support context-specific recommendations in sub-Saharan Africa. These sources establish the importance of context; neither demonstrates biostimulant efficacy across Africa. [3][4]
What the evidence says
Under the EU definition, a plant biostimulant stimulates plant nutrition processes independently of its nutrient content, aiming to improve one or more of four characteristics: nutrient use efficiency, tolerance to abiotic stress, quality traits, or availability of nutrients confined in the soil or rhizosphere. [1]
This definition describes intended functions. It does not guarantee that a particular product will achieve them. A biostimulant is not defined primarily by supplying nutrients, and the definition does not mean that biostimulants replace fertilizers or correct nutrient deficiencies by themselves.
A field-trial meta-analysis of non-microbial biostimulants found that marketable-yield responses varied with product category, application method, crop, climate and soil properties. The studies were concentrated in Eurasia and the Mediterranean; only one was conducted in Southern Africa. [2]
Interpreting the evidence for a local decision
Our interpretation is to keep three questions connected. First, identify the intended function. Second, examine the crop and growing conditions under which the claimed effect was demonstrated. Third, assess the strength and relevance of that evidence to the proposed use.
The EU definition provides a framework for describing function; the meta-analysis provides evidence from non-microbial biostimulant field trials. Neither establishes the performance of a specific GreeVo formulation.
Where evidence from comparable crops and growing conditions is limited, local field validation may be necessary before broad recommendations. This is a conditional judgment about an evidence gap, rather than a requirement that every evaluation must include a new field trial.
GreeVo perspective
For GreeVo’s Africa work, this framework helps connect plant and soil science with local validation and business development. Based on the evidence above, our current view is that the intended function, the conditions of use and the available evidence should be considered together when framing a local validation question.
That question sits alongside the local resources, supply chains and commercial feasibility considered in our Africa work. This article explains an approach to evaluation; it does not report GreeVo field results or establish product performance, fertilizer replacement or a commercial outcome.
References
- European Union (2019). Regulation (EU) 2019/1009, Annex I, PFC 6: Plant Biostimulant.
- Li, J., Van Gerrewey, T., and Geelen, D. (2022). A Meta-Analysis of Biostimulant Yield Effectiveness in Field Trials. Frontiers in Plant Science, 13, 836702. DOI: 10.3389/fpls.2022.836702.
- European Commission Joint Research Centre (2013). Soil Atlas of Africa. Soil map resource.
- FAO. About SoilFER: Our Focus.